Добавил:
Sekretar
kiopkiopkiop18@yandex.ru
t.me/Prokururor I Вовсе не секретарь, но почту проверяю
Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз:
Предмет:
Файл:Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_236_библиотеки_им_акад_М_И_Перельмана
.pdf
151
Moccetti [et al.] // Revista española de cardiología. – 2019. – Vol. 72, № 5. – P. 383–
391.
103. New-onset versus chronic atrial fibrillation in acute myocardial infarction:
differences in short- and long-term follow-up / P. Maagh, T. Butz, I. Wickenbrock [et
al.] // Clinical research in cardiology. – 2011. – Vol. 100, № 2. – P. 167–175.
104. Niccoli, G. Acute myocardial infarction with no obstructive coronary
atherosclerosis: mechanisms and management / G. Niccoli, G. Scalone, F. Crea //
European heart journal. – 2015. – Vol. 36, № 8. – P. 475–481.
105. Optimal antithrombotic regimens for patients with atrial fibrillation
undergoing percutaneous coronary intervention: an updated network meta-analysis / R.
D. Lopes, H. Hong, R. E. Harskamp [et al.] // JAMA cardiology. – 2020. – Vol. 5, № 5.
– P. 582–589.
106. Oral anticoagulation and antiplatelets in atrial fibrillation patients after
myocardial infarction and coronary intervention / M. Lamberts, G. H. Gislason, J. B.
Olesen [et al.] // Journal of the American College of Cardiology. – 2013. – Vol. 62, №
11. – P. 981–989.
107. Poor adherence to guideline recommendations among patients with atrial
fibrillation and acute myocardial infarction / J. Jortveit, A. H. Pripp, J. Langørgen, S.
Halvorsen // European journal of preventive cardiology. – 2019. – Vol. 26, № 13. – P.
1373–1382.
108. Prediction of mortality after primary percutaneous coronary intervention
for acute myocardial infarction: the CADILLAC risk score / A. Halkin, M. Singh, E.
Nikolsky [et al.] // Journal of the American College of Cardiology. – 2005. – Vol. 45, №
9. – P. 1397–1405.
109. Predictions and outcomes of atrial fibrillation in the patients with acute
myocardial infarction / M. Vukmirovic, A. Boskovic, I. Tomasevic Vukmirovic [et al.]
// Open medicine. – 2017. – Vol. 12. – P. 115–124.
110. Prevalence, clinical features, and prognosis of acute myocardial infarction
attributable to coronary artery embolism / T. Shibata, S. Kawakami, T. Noguchi [et al.]
// Circulation. – 2015. – Vol. 132, № 4. – P. 241–250.
https://t.me/med1917
152
111. Prevalence, clinical profile, and cardiovascular outcomes of atrial
fibrillation patients with atherothrombosis / S. Goto, D. L. Bhatt, J. Röther [et al.] //
American heart journal. – 2008. – Vol. 156, № 5. – P. 855–863.
112. Prevention of bleeding in patients with atrial fibrillation undergoing PCI /
C. M. Gibson, R. Mehran, C. Bode [et al.] // The New England journal of medicine. –
2016. – Vol. 375, № 25. – P. 2423–2434.
113. Prizel, K. R. Coronary artery embolism and myocardial infarction. A
clinicopathologic study of 55 patients / K. R. Prizel, G. M. Hutchins, B. H. Bulkley //
Annals of internal medicine. – 1978. – Vol. 88, № 2. – P. 155–161.
114. Prognostic impact of types of atrial fibrillation in acute coronary
syndromes / D. H. Lau, L. T. Huynh, D. P. Chew [et al.] // The American journal of
cardiology. – 2009. – Vol. 104, № 10. – P. 1317–1323.
115. Prognostic risk of atrial fibrillation in acute myocardial infarction
complicated by left ventricular dysfunction: the OPTIMAAL experience / M. Lehto, S.
Snapinn, K. Dickstein [et al.] // European heart journal. – 2005. – Vol. 26, № 4. – P.
350–356.
116. Prognostic value and determinants of CMR-derived left atrial function
assessed in STEMI / J. Ledwoch, T. Stiermaier, G. Fuernau [et al.] // JACC.
Cardiovascular imaging. – 2018. – Vol. 11, № 1. – P. 148–150.
117. Randomized trial of primary PCI with or without routine manual
thrombectomy / S. S. Jolly, J. A. Cairns, S. Yusuf [et al.] // The New England journal of
medicine. – 2015. – Vol. 372, № 15. – P. 1389–1398.
118. Recent trends in oral anticoagulant use and post-discharge complications
among atrial fibrillation patients with acute myocardial infarction / A. Kundu, K. O.
Day, D. M. Lessard [et al.] // Journal of atrial fibrillation. – 2018. – Vol. 10, № 5. –
Article 1749.
119. Refining clinical risk stratification for predicting stroke and
thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro
heart survey on atrial fibrillation / G. Y. H. Lip, R. Nieuwlaat, R. Pisters [et al.] // Chest.
– 2010. – Vol. 137, № 2. – P. 263–272.
https://t.me/med1917
153
120. Risk of myocardial infarction in patients with long-term non-vitamin K
antagonist
oral anticoagulant treatment / A. Tornyos, D. Kehl, F. D’Ascenzo, A. Komócsi //
Progress in cardiovascular diseases. – 2016. – Vol. 58, № 5. – P. 483–494.
121. Rivaroxaban versus warfarin in nonvalvular atrial fibrillation / M. R. Patel,
K. W. Mahaffey, J. Garg [et al.] // The New England journal of medicine. – 2011. –
Vol. 365, № 10. – P. 883–891.
122. Routine aspiration thrombectomy improves the diagnosis and management
of embolic myocardial infarction / A. L. Huang, J. C. Murphy, E. Shaw [et al.] //
Catheterization and cardiovascular interventions. – 2016. – Vol. 87, № 4. – P. 642–647.
123. Sex differences in patient characteristics, treatment strategies, and
outcomes for
type 2 myocardial infarction / C. P. McCarthy, S. Murphy, J. A. Cohen [et al.] // Journal
of the American College of Cardiology. – 2019. – Vol. 73, № 24. – P. 3230–3232.
124. Short- and long-term outcomes following atrial fibrillation in patients with
acute coronary syndromes with or without ST-segment elevation / R. D. Lopes, K. S.
Pieper, J. R. Horton [et al.] // Heart. – 2008. – Vol. 94, № 7. – P. 867–873.
125. Short- and long-term prognosis of previous and new-onset atrial fibrillation
in ST-segment elevation acute myocardial infarction / L. Consuegra-Sanchez, A.
Melgarejo-Moreno, J. Galcera-Tomas [et al.] // Revista española de cardiología. – 2015.
– Vol. 68, № 1. – P. 31–38.
126. Stenestrand, U. Anticoagulation therapy in atrial fibrillation in combination
with acute myocardial infarction influences long-term outcome: a prospective cohort
study from the Register of Information and Knowledge About Swedish Heart Intensive
Care Admissions (RIKS-HIA) / U. Stenestrand, J. Lindbäck, L. Wallentin // Circulation.
– 2005. – Vol. 112, № 21. – P. 3225–3231.
127. Stent thrombosis in patients with atrial fibrillation undergoing coronary
stenting in the AUGUSTUS trial / R. L. Lopes, S. Leonardi, D. M. Wojdyla [et al.] //
Circulation. – 2020. – Vol. 141, № 9. – P. 781–783.
https://t.me/med1917
154
128. Temporal trends in the occurrence and outcomes of atrial fibrillation in
patients with acute myocardial infarction (from the atherosclerosis risk in communities
surveillance study) / L. G. S. Bengtson, L. Y. Chen, A. M. Chamberlain [et al.] // The
American journal of cardiology. – 2014. – Vol. 114, № 5. – P. 692–697.
129. Third universal definition of myocardial infarction / K. Thygesen, J. S.
Alpert, A. S. Jaffe [et al.] // Global heart. – 2012. – Vol. 7, № 4. – P. 275–295.
130. Thrombolysys in Myocardial Infarction (TIMI) Trial-phase I: hemorragic
manifestations and changes in plasma fibrinogen and the fibrinolytic system in patients
treated with recombinant tissue plasminogen activator and streptokinase / A. K. Rao, C.
Pratt, A. Berke [et al.] // Journal of the American College of Cardiology. – 1988. – Vol.
11, № 1. – P. 1–11.
131. Thrombus aspiration during ST-segment elevation myocardial infarction /
O. Fröbert, B. Lagerqvist, G. K. Olivecrona [et al.] // The New England journal of
medicine. – 2013. – Vol. 369, № 17. – P. 1587–1597.
132. Thrombus aspiration in ST-segment–elevation myocardial infarction. An
individual patient meta-analysis: thrombectomy trialists collaboration / S. S. Jolly, S.
James, V. Džavík [et al.] // Circulation. – 2017. – Vol. 135, № 2. – P. 143–152.
133. Type 2 myocardial infarction: a geriatric population-based model of
pathogenesis / A. Putot, M. Jeanmichel, F. Chague [et al.] // Aging and disease. – 2020.
– Vol. 11, № 1. – P. 108–117.
134. Use and outcomes of triple therapy among older patients with acute
myocardial infarction and atrial fibrillation / C. N. Hess, E. D. Peterson, S. A. Peng [et
al.] // Journal of the American College of Cardiology. – 2015. – Vol. 66, № 6. – P. 616–
627.
135. Use of clopidogrel with or without aspirin in patients taking oral
anticoagulant therapy and undergoing percutaneous coronary intervention: an open-
label, randomised, controlled trial / W. J. M. Dewilde, T. Oirbans, F. W. A. Verheugt
[et al.] // Lancet. – 2013. – Vol. 381, № 9872. – P. 1107–1115.
https://t.me/med1917
155
136. Worldwide epidemiology of atrial fibrillation: a Global Burden of Disease
2010 Study / S. S. Chugh, R. Havmoeller, K. Narayanan [et al.] // Circulation. – 2014. –
Vol. 129, № 8. – P. 837–847.
https://t.me/med1917
Соседние файлы в папке Библиотека им академика М.И. Перельмана